Eureka Bio
PrivateLast Round
Series B
Feb 21, 2024
Total Funding Raised
$54.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Eureka Bio operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Series B round in February 2024.
Eureka Bio is a biotechnology company that provides automated cell processing systems and viral vector manufacturing platforms for the cell and gene therapy (CGT) industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Smart Manufacturing, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eureka Bio Comparables
Compare Eureka Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shenzhen Cellbri Bio-Innovation Technology Co., Ltd. | 82% | |
| Ori Biotech | 80% | |
| Scinogy | 77% |
For institutional investors. Book with your work email.
Eureka Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 21, 2024 | ||||
| Series B | Jun 21, 2022 | ||||
| Series A | Apr 23, 2021 | ||||
| Pre Seed | Oct 1, 2020 | ||||
| Angel | Dec 1, 2018 |
For institutional investors. Book with your work email.
Eureka Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ABC Capital | Series B |
| F-Prime Capital | Series B |
| Eight Roads Ventures | Series B |
| Shenzhen Dachen Caizhi Venture Capital Management | Series B |
| Clearwater Bay Capital | Series B |
| Tasly Capital | Series B |
| Guangzhou Yuexiu Industrial Investment Fund Management | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 32% MoM.
- May 16, 2026
Monthly visitors grew 382% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Eureka Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eureka Bio's valuation, stock price, and market status.
Is Eureka Bio a public or private company?
Eureka Bio is a private company.
What is the current stock price of Eureka Bio?
Eureka Bio is a private company, so its shares have no public market price. Caplight tracks Eureka Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eureka Bio worth (valuation)?
Valuation information for Eureka Bio is not publicly available.
Can I buy Eureka Bio stock?
Eureka Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eureka Bio's last funding round?
Eureka Bio's most recent funding round was Series B on February 21, 2024.
Who are the main investors in Eureka Bio?
Key investors in Eureka Bio include Eight Roads Ventures, Guangzhou Yuexiu Industrial Investment Fund Management.
Will Eureka Bio IPO soon?
No public IPO plans have been announced for Eureka Bio.
How can I track Eureka Bio secondary market activity?
Caplight tracks bids, offers, and trades in Eureka Bio's shares on secondary markets.